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TLR9-Dependent Recognition of MCMV by IPC
and DC Generates Coordinated Cytokine Responses
that Activate Antiviral NK Cell Function
waki et al., 2000; Olweus et al., 1997; Strobl et al., 1998).
Because of this T cell stimulatory capacity and the lack
of lineage markers, IPC are also regarded as a subset
of dendritic cells, plasmacytoid DC (pDC). When ex-
posed to viruses in vitro, human IPC secrete not only
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tribute significantly to antiviral responses and, in gen-Japan
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Consistent with this hypothesis, human IPC are particu-Bergisch Gladbach
larly abundant in inflamed lymph nodes caused by cer-Germany
tain viruses, bacteria, and autoimmune diseases as well
as in the skin of patients with systemic lupus erythema-
tosus (Facchetti et al., 2003; Farkas et al., 2001; Ronn-Summary
blom and Alm, 2001).
While human IPC were characterized over 20 yearsNatural interferon-producing cells (IPC) respond to vi-
ago, their murine counterparts were identified very re-ruses by secreting type I interferon (IFN) and interleu-
cently (Asselin-Paturel et al., 2001; Bjorck, 2001; Nakanokin-12 (IL-12). Toll-like receptor (TLR) 9 mediates IPC
et al., 2001). Murine IPC represent less than 1% of spleenrecognition of some of these viruses in vitro. However,
and lymph node cells, and their number varies consider-whether TLR9-induced activation of IPC is necessary
ably in different mouse strains (Asselin-Paturel et al.,for an effective antiviral response in vivo is not clear.
2003; Nakano et al., 2001). Complicating analysis, mu-Here, we demonstrate that IPC and dendritic cells (DC)
rine IPC have a complex phenotype, distinguished byrecognize murine cytomegalovirus (MCMV) through
expression of CD11c, Ly-6C, and B220 and lack ofTLR9. TLR9-mediated cytokine secretion promotes vi-
CD11b expression (Asselin-Paturel et al., 2001; Bjorck,ral clearance by NK cells that express the MCMV-
2001; Nakano et al., 2001). When exposed to virusesspecific receptor Ly49H. Although depletion of IPC
in vitro, murine IPC produce high levels of both type Ileads to a drastic reduction of the IFN- response,
IFN, IL-12, and chemokines (Asselin-Paturel et al., 2001;this allows other cell types to secrete IL-12, ensuring
Dalod et al., 2002; Krug et al., 2002). In addition, IPCnormal IFN- and NK cell responses to MCMV. We
are an important source of IFN- and IL-12 in vivo duringconclude that the TLR9/MyD88 pathway mediates
murine cytomegalovirus (MCMV) and vesiculostomatitisantiviral cytokine responses by IPC, DC, and possibly
virus (VSV) infection (Barchet et al., 2002; Dalod et al.,other cell types, which are coordinated to promote
2002), while lymphochoriomeningitis virus (LCMV) infec-effective NK cell function and MCMV clearance.
tion does not elicit IPC responses (Dalod et al., 2002).
Although considered a DC subset, murine IPC present
Introduction antigens much less efficiently than do classical DC (As-
selin-Paturel et al., 2001; Boonstra et al., 2003; Brawand
Interferon-producing cells (IPC) are a very small subset et al., 2002; Krug et al., 2003). Therefore, IPC may play
of cells originally found in human blood and lymph nodes a limited role in expanding antigen-specific naive T cells
that secrete large amounts of IFN- and IFN- in re- but maintain a more predominant role in inducing Th1
sponse to DNA and RNA viruses (Cella et al., 1999; differentiation of antigen-primed T cells by secreting the
Fitzgerald-Bocarsly, 1993; Perussia et al., 1985; Ronn- Th1 polarizing cytokines and chemokines (Aliberti et al.,
blom et al., 1983; Siegal et al., 1999). Human IPC have 2000; Dalod et al., 2002; Krug et al., 2003; Zou et al.,
a plasma cell-like morphology and express several 2001).
lymphoid and myeloid markers but lack lineage markers Recently, attention has focused on the mechanisms
(Facchetti et al., 2003; Vollenweider and Lennert, 1983). by which IPC respond to viruses (Lund et al., 2003).
They also express major histocompatibility complex Because IPC respond to a wide spectrum of DNA and
(MHC) class II molecules and stimulate helper T cell RNA viruses, it seems probable that IPC detect most of
proliferation and differentiation in vitro (Cella et al., 1999, them through pattern recognition receptors, like the Toll-
2000; Fonteneau et al., 2003; Grouard et al., 1997; Kado- like receptors (TLR) (Janeway and Medzhitov, 2002;
Medzhitov, 2001; Vaidya and Cheng, 2003). IPC express
TLR7, TLR8, and TLR9 (Bauer et al., 2001; Boonstra et*Correspondence: mcolonna@pathology.wustl.edu
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et al., 2001; Kadowaki et al., 2001; Krug et al., 2001). secretion of MIP-1 in the liver, which recruits NK cells
TLR7 and TLR8 recognize antiviral compounds known and macrophages (Salazar-Mather et al., 2002). How-
as imidazoquinolins (Hemmi et al., 2002) and single- ever, it is unclear how MCMV elicits cytokine and chemo-
stranded RNA viruses (Diebold et al., 2004; Heil et al., kine responses by IPC and DC and whether these re-
2004; Lund et al., 2004). TLR9 recognizes unmethylated sponses are required for NK cell-mediated defense
CpG motifs that are present in bacterial DNA or synthetic against MCMV infection. In this study, we demonstrate
oligonucleotides (Bauer et al., 2001; Hemmi et al., 2000; that TLR9 is a pattern recognition receptor for MCMV
Krieg, 2002). All of these TLRs transduce intracellular in IPC and DC and that TLR9/MyD88 mediates a coordi-
signals through the adaptor molecule MyD88, which ulti- nate cytokine secretion by IPC, DC, and possibly other
mately leads to NF-kB/AP1 activation and transcription cell types, which is essential for rapid and efficient acti-
of genes encoding proinflammatory cytokines and che- vation of MCMV-specific NK cell responses.
mokines (Hacker et al., 2000; Hemmi et al., 2002). Be-
cause some DNA viruses contain abundant CpG motifs Results
(Lundberg et al., 2003; Zheng et al., 2002), IPC may
recognize them through TLR9. This is the case for herpes MCMV Activates IPC and DC In Vitro through
simplex virus (HSV)-1 and HSV-2. TLR9 is required for a MyD88-Dependent Signaling Pathway
IPC secretion of IFN- after exposure to HSV-2 and Because IPC and DC responses to other DNA viruses are
HSV-1 in vitro (Krug et al., 2003; Lund et al., 2003) and MyD88 dependent (Krug et al., 2004; Lund et al., 2003), it
injection of UV inactivated HSV-2 in vivo (Lund et al., was plausible that MyD88 is also required for activation
2003). However, TLR9 and MyD88 mice control HSV-1 of IPC and DC by MCMV in vitro. To address this, CD11c
infection induced by either footpad or eye inoculation, cells isolated from splenocytes of MyD88 and wild-type
suggesting that TLR9/MyD88-independent immune re- mice were cultured with increasing doses of MCMV or
sponses mediated by cells other than IPC are sufficient CpG ODN 2216; IFN- and IL-12 secretion into superna-
to control local HSV-1 infection (Krug et al., 2003). Thus, tants was determined after 36 hr. MyD88CD11c sple-
the physiological significance of TLR9-mediated activa- nocytes did not produce significant amounts of IFN-
tion of IPC in the generation of an effective antiviral and IL-12 in response to MCMV or CpG in contrast
response in vivo is unclear. to wild-type cells (Figure 1A). IPC, which are the main
To clarify the role of TLR9-mediated activation of IPC producers of IFN- and release considerable amounts of
in antiviral immunity, we focused on systemic infection, IL-12 in response to MCMV (Dalod et al., 2002), represent
in particular that caused by MCMV, in which the virus less than 5% of CD11c splenocytes in C57BL/6 mice
can interact with IPC in blood, spleen, and lymph nodes. (Asselin-Paturel et al., 2001). The remaining 95% of
MCMV is an enveloped double-stranded DNA virus of CD11c cells include CD11b and CD11b DC, which
the  subfamily of herpesviridae that is widely used as can also secrete cytokines when triggered by MCMV
a model for human CMV infection (Mocarski and Kemble, (Dalod et al., 2002). To determine whether all three sub-
1996), providing information on host defense mecha- populations require MyD88 to respond to MCMV, IPC,
nisms as well as viral genes affecting the immune control CD11b DC, and CD11b DC were sorted from wild-
(Alcami and Koszinowski, 2000). After infection, MCMV type and MyD88CD11c splenocytes and cultured with
spreads through the blood, reaching the spleen and MCMV in vitro to induce IFN- and IL-12 production.
liver. To counteract MCMV infection, the host launches MyD88 IPC did not respond to MCMV, whereas wild-
both innate and adaptive immune responses, after which type splenic IPC secreted large amounts of IFN- (Figure
MCMV remains latent, particularly in the acinous epithe-
1B). CD11b and CD11b DC produced negligible
lial cells of salivary glands. During the early innate phase
IFN- in response to MCMV. However, all three subpop-
of defense, natural killer (NK) cells play a crucial role in
ulations isolated from wild-type mice secreted measur-host survival by killing infected cells in the spleen and
able IL-12, whereas no IL-12 was detectable in superna-producing IFN- in the liver (Biron et al., 1999; Tay et
tants of MyD88 subsets, indicating that cytokineal., 1998). NK cells recognize MCMV-infected cells
responses of IPC and DC subsets to MCMV are MyD88through the activating receptor Ly49H (Brown et al.,
dependent. The effect of MyD88 deficiency on MCMV-2001; Daniels et al., 2001; Lee et al., 2001), which inter-
induced activation of IPC was also investigated usingacts with the MCMV-encoded protein m157 on the sur-
IPC derived from bone marrow cells (Figure 1C). Evenface of infected cells (Arase et al., 2002; Smith et al.,
at high doses of MCMV, IFN- and IL-12 secretion as2002). Importantly, Ly49H is expressed only on NK cells
well as upregulation of CD86 expression was almostin C57BL/6 (B6) mice, which control viral replication in
entirely dependent on signaling through MyD88. Wethe spleen and survive infection with high doses of
conclude that in vitro responses of IPC and DC to MCMVMCMV. In contrast, BALB/c, 129/J and DBA/2 mice do
are MyD88 dependent.not express Ly49H; therefore, these mice develop ele-
vated splenic viral titers and succumb to infection with
TLR9 Mediates IPC and DC Responseshigh doses of MCMV within a week of infection.
to MCMV In VitroThat cytokines and chemokines released by IPC and
Because MyD88 is an adaptor molecule that mediatesDC during MCMV infection activate NK cell responses
signaling of multiple receptors, including TLRs and thehas been documented (Andrews et al., 2001; Dalod et
IL-1 and IL-18 receptors, we asked which of these recep-al., 2002, 2003; Orange and Biron, 1996a, 1996b). Type
tors mediates IPC and DC responses to MCMV. TLR9I IFNs, IL-12, IL-18, and IL-15 promote cytotoxicity, IFN-
was an obvious candidate for two reasons: (1) TLR9 isproduction, and proliferation of NK cells (Andrews et
al., 2001; Nguyen et al., 2002). Type I IFNs also induce expressed in all murine IPC and DC subpopulations and
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Figure 1. MyD88-Dependent Activation of IPC and DC by MCMV In Vitro
(A) CD11c splenocytes were isolated from wild-type (filled bars) and MyD88 (hatched bars) mice and cultured for 36 hr (2  106 cells/ml)
with MCMV (0.008–1 MOI) or CpG ODN 2216 (3 g/ml).
(B) IPC (upper panels), CD11b DC (middle panels), and CD11b DC (lower panels) were sorted from wild-type and MyD88CD11c splenocytes
and cultured with 1 MOI MCMV or 3 g/ml CpG ODN 2216 for 36 hr (5  104 cells/150 l/well).
(C) Bone marrow-derived wild-type and MyD88 IPC were incubated with MCMV (0.008–1 MOI) or CpG ODN 2216 (3 g/ml) for 36 hr at 1 
106 cells/ml. IFN- and IL-12 were measured in the supernatants by ELISA. CD86 expression was measured by flow cytometry and is expressed
as median fluorescence intensity.
signals exclusively through MyD88 (Boonstra et al., secreted significantly less IFN- and IL-12 when ex-
posed to MCMV than did their wild-type counterparts.2003; Edwards et al., 2003); (2) TLR9 mediates recogni-
tion of other DNA viruses, including HSV-1 and -2 (Krug MCMV-induced upregulation of the costimulatory mole-
cule CD86 was also significantly reduced on TLR9 BM-et al., 2004; Lund et al., 2003). To investigate the role
of TLR9, we isolated CD11c splenocytes from TLR9 derived IPC, although not entirely abrogated. Again, lack
of TLR9 did not impair activation of IPC by influenza virusand wild-type mice and cultured them with different
doses of MCMV as well as CpG ODN 2216 and influenza PR8. We conclude that IPC and DC recognize MCMV
through TLR9, whereas recognition of influenza virus isvirus PR8 as controls. IFN- and IL-12 responses to
MCMV and CpG were dramatically reduced in TLR9 independent.
TLR9CD11c cells but the IFN- response to influenza
virus remained intact (Figure 2A). Reduced Activation of DC and IPC during MCMV
Infection in TLR9-Deficient Mice In VivoSimilarly, TLR9 IPC sorted from CD11c splenocytes
did not secrete IFN- and IL-12 in response to MCMV, To determine whether TLR9 mediates recognition of
MCMV by splenic IPC and DC in vivo, TLR9 and wild-although they did in response to Influenza virus (Figure
2B). IL-12 secretion of CD11b and CD11b DC in- type mice were infected intraperitoneally with 2  104
PFU MCMV per mouse. CD11c cells were purified fromduced by MCMV was also affected by TLR9 deficiency
(Figure 2B), whereas IFN- secretion by CD11b and splenocytes of infected mice 36 hr after inoculation,
and cytokine secretion was assessed without additionalCD11b DC was below the detection limit of the ELISA
for both TLR9 and wild-type DC. These results indicate stimulation. CD11c cells isolated from infected TLR9
mice secreted significantly less IFN- and IL-12 thanthat TLR9 deficiency selectively impairs MCMV recogni-
tion without debilitating responses to influenza virus. did wild-type cells (Figure 3A). The relative percentages
of IPC and DC subpopulations were similar in CD11cThat TLR9 is required for recognition of MCMV by IPC
was confirmed using bone marrow-derived IPC (Figure cells isolated from TLR9 and wild-type mice (data not
shown). However, TLR9 IPC, CD11bDC, and CD11b2C). IPC cultured from TLR9 bone marrow precursors
Immunity
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Figure 2. TLR9-Dependent Activation of IPC and DC by MCMV In Vitro
(A) CD11c splenocytes were isolated from wild-type (filled bars) and TLR9 (hatched bars) mice and cultured for 36 hr (2  106 cells/ml) with
MCMV (0.008–1 MOI), influenza virus PR8 (1 MOI), or CpG ODN 2216 (3 g/ml).
(B) IPC (upper panels), CD11b DC (middle panels), and CD11b DC (lower panels) were sorted from wild-type and TLR9CD11c splenocytes
and cultured with 2 MOI MCMV or 2 MOI influenza virus PR8 for 36 hr (1  104 cells/100 l/well).
(C) Bone marrow-derived wild-type and TLR9 IPC were incubated with MCMV (0.008–1 MOI), influenza virus PR8 (1 MOI), or CpG ODN 2216
(3 g/ml) for 36 hr at 1  106 cells/ml. IFN- and IL-12 were measured in the supernatants by ELISA. CD86 expression was measured by flow
cytometry and is expressed as median fluorescence intensity.
DC expressed lower levels of CD86 after in vivo expo- points, substantial serum levels of IFN-, IL-12, and MIP-
1 were observed in the absence of MyD88 or TLR9,sure to MCMV than did wild-type cells (Figure 3B). A
residual response of TLR9 IPC and DC to MCMV was suggesting that the lack of TLR9 is partially compen-
sated in vivo by TLR9-independent mechanisms.detectable, suggesting that additional TLR9-indepen-
dent mechanisms exist in vivo, which lead to a partial
activation of IPC and DC during MCMV infection.
Lack of MyD88 or TLR9 Affects Early NK Cell
Activation during MCMV Infection
IFN- plays an important role in the response to MCMV,The Serum Cytokine Response to MCMV Infection
Is Impaired and Delayed in the Absence in part by interfering with viral replication, in part by
activating host immune responses. Among others, IFN-of TLR9/MyD88 Signaling
Because IPC and DC are a major source of proinflamma- activates NK cells, which dominate the early host re-
sponse against MCMV. IL-12 also activates NK cells,tory cytokines and chemokines secreted in response to
viral infections, we measured IFN-, IL-12, and MIP- and MIP-1 recruits NK cells to the site of infection.
Thus, the delayed secretion of IFN-, IL-12, and MIP-1 in the serum of MCMV-infected MyD88 (Figure 4A),
TLR9 (Figure 4B), and wild-type mice. MCMV infection 1 observed in MyD88 and TLR9 mice may impair
cytolytic activity and IFN- secretion of NK cells.induced a significant increase in serum levels of IFN-,
IL-12, and MIP-1 in wild-type mice, which peaked be- To address this possibility, MyD88 and wild-type
mice were infected intraperitoneally with 5  104 PFUtween 36 and 48 hr. In MyD88 and TLR9 mice, this
increase was remarkably less pronounced and was de- of MCMV. After 36 hr, we analyzed expression of the
early activation marker CD69 as well as intracellularlayed in comparison to wild-type mice. As shown in
Figure 4C, the difference in cytokine serum levels be- IFN- in CD3-/NK1.1 splenic NK cells by flow cytome-
try (Figures 5A, 5B, and 5C). NK cells from MCMV-tween TLR9 and wild-type mice was highly significant
36 hr after infection (p 	 0.002, n 
 6). Only at later time infected MyD88 mice did upregulate CD69 on the cell
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defect in NK cell proliferation in MyD88 mice, rather a
delay in NK cell expansion.
To investigate the effect of MyD88 deficiency on cyto-
lytic activity of NK cells during MCMV infection, NK cells
were isolated from wild-type and MyD88 mice 36 hr
after infection with 5 104 PFU i.p. and used as effector
cells in a 4 hr chromium release assay against the tumor
cell line RMA-S (Figure 5E). NK cells from infected mice
lysed RMA-S cells more efficiently than NK cells from
uninfected mice regardless of genotype, but the cyto-
lytic activity of NK cells isolated from infected MyD88
mice was approximately 50% that of NK cells isolated
from infected wild-type mice. Together, these results
demonstrate that MyD88 deficiency impairs NK cell acti-
vation, proliferation, IFN- secretion, and cytotoxicity
following MCMV infection in vivo. Finally, we analyzed
CD69 expression (Figure 5F) and intracellular IFN- con-
tent (Figures 5G and 5H) in splenic NK cells from TLR9
and control mice after MCMV infection. NK cell activa-
tion following MCMV infection was also reduced in
TLR9 mice, although less markedly than in MyD88
mice; this probably reflects partial compensation by
TLR9-independent MyD88-dependent mechanisms.
It has been reported that TLR9 is not expressed in
human NK cells (Hornung et al., 2002). However, murine
NK cells may express this receptor. If so, the defect in
NK cell responses to MCMV observed in MyD88 and
TLR9 mice could reflect lack of direct activation rather
than decreased production of cytokines that activate NK
cells. To address this possibility, NK cells were isolated
from uninfected wild-type mice and cultured for 24 hr
Figure 3. Cytokine Production and Expression of CD86 in TLR9DC in IL-2-containing medium in the presence or absence
and IPC in Response to MCMV In Vivo of MCMV. In control experiments, NK cells were cultured
(A) CD11c splenocytes were enriched from wild-type BALB/c and with CpG ODN 2216 and HSV-1, which are known TLR9
TLR9 mice 36 hr after infection with 2  104 PFU of MCMV and agonists. Neither MCMV nor other TLR9 agonists trig-
cultured for 24 hr in medium without additional stimulation. Sponta- gered CD69 expression or IFN- production in isolated
neously released IFN- and IL-12 were measured in the superna-
NK cells in vitro (see Supplemental Figure S1A, left panels,tants by ELISA and are expressed as pg/100,000 CD11c cells
at http://www.immunity.com/cgi/content/full/21/1/107/to correct for differences in the percentage of CD11c cells after
DC1; Figure 1B). However, CD69 upregulation and IFN-enrichment with magnetic beads.
(B) Expression of CD86 in CD11c/Ly-6G/C IPC (upper panel), secretion were induced efficiently in purified NK cells
CD11c/CD11b DC (middle panel), and CD11c/CD8 DC cultured with conditioned medium from MCMV- and
(CD11b DC, lower panel) was determined by flow cytometry and CpG-stimulated IPC or recombinant IFN- and IL-12
is expressed as mean fluorescence intensity (MFI). Mean values 
(Supplemental Figures S1A, right panels, and S1B onstandard deviations are shown (n
 3). Statistically significant differ-
Immunity’s website). The absence of TLR9 expressionences are indicated by asterisks (p 	 0.05).
in freshly isolated spleen NK cells was confirmed by
PCR (Supplemental Figure S1C on Immunity’s website).
We conclude that reduced NK cell activation in TLR9surface and secrete IFN-. However, the levels of CD69
mice infected with MCMV is not due to lack of directexpression on NK cells and the percent of IFN--
NK cell stimulation through TLR9 but to impaired IPCexpressing NK cells were significantly lower in infected
and DC cytokine-mediated help to NK cells.MyD88 than in infected control mice. IFN- production
was also impaired in liver NK cells from infected MyD88
mice in comparison to infected wild-type mice (data not MyD88 and TLR9 Mice Inefficiently Control MCMV
Replication In Vivoshown). Impairment of IFN- production in MyD88 NK
cells was seen regardless of Ly-49H expression. We NK cells recognize MCMV-infected cells with the activat-
ing receptor Ly-49H, which specifically interacts withalso measured proliferation of NK cells 2 days after
MCMV infection using a 3 hr in vivo BrdU incorporation the MCMV-encoded class I-like protein m157 on virally
infected cells (Arase et al., 2002; Smith et al., 2002).assay. The percentage of proliferating NK cells (13.6%
3.2%) in MCMV-infected MyD88 mice was only half Ly49H is selectively expressed in C57BL/6 mice, which
successfully control MCMV replication and survive in-that observed in wild-type mice (26.5%  2.7%) 2 days
postinfection (Figure 5D). However, at later time points fection with high doses of MCMV. In contrast, BALB/c
mice do not express Ly49H and succumb to infection(4 to 5 days after infection), the percent of proliferating
NK cells in MyD88 and wild-type mice were similar (data with low doses of MCMV. Given this, the impaired NK cell
activation observed in MyD88 and TLR9 mice mightnot shown), suggesting that there is not a sustained
Immunity
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Figure 4. Serum Cytokine Response in MyD88 and TLR9 Mice during MCMV Infection
(A and B) MyD88 and C57BL/6 wild-type mice were infected with 5  104 PFU i.p. ([A], n 
 3). TLR9 and BALB/c wild-type mice were infected
with 2  104 PFU i.p. ([B], n 
 3). Serum levels of IFN-, IL-12, and MIP-1 were measured by ELISA at the indicated time points. Mean
values  SEM are shown.
(C) Values obtained from six wild-type and six TLR9 mice 36 hr after intraperitoneal infection with 2  104 PFU. Statistically significant
differences (p 	 0.002) are indicated by asterisks.
severely hamper the ability of C57BL/6 mice to control control of MCMV infection in MyD88 and TLR9 mice,
we compared MCMV titers in C57BL/6 and MyD88miceMCMV replication but have minimal consequences in
BALB/c mice. To test this hypothesis, we compared after blocking Ly49H in vivo with the 3D10 mAb (Smith
et al., 2002). MCMV titers in C57BL/6 mice treated withsplenic viral titers in MyD88, TLR9, and wild-type mice
on the C57BL/6 background after intraperitoneal infec- mAb 3D10 were as high as those observed in MyD88
mice, significantly higher than untreated C57BL/6 con-tion with 5  104 PFU MCMV. Splenic viral titers were
approximately three log higher in MyD88 mice than in trols (Supplemental Figure S2 on Immunity’s website).
In contrast, blockade of Ly49H in MyD88 mice did notwild-type mice 3.5 days postinfection (Figure 6A). Six
days after infection, wild-type mice had successfully lead to any significant further increase in splenic viral
titers in comparison to untreated MyD88 controls. Thiscleared virus from the spleen, whereas significant
MCMV titers were still detectable in spleens of MyD88 result indicates a substantial correspondence between
the effects of Ly49H blockade and MyD88 deficiency.mice (Figure 6B). Significantly higher MCMV titers were
also observed in the spleens of TLR9mice on a C57BL/6 To corroborate this conclusion, we measured viral titers
in TLR9mice on a BALB/c background (TLR9/BALB/c)background (TLR9/B6) as compared to wild-type mice
3 days after infection (Figure 6C). However, the differ- and BALB/c control mice, which lack Ly49H. MCMV
titers were high in both TLR9/BALB/c (Figures 6D andence was less pronounced than that between wt and
MyD88 mice, indicating that the defect in antiviral re- 6E) and wt BALB/c mice, with no significant difference
at 3 and 6 days postinfection. Only after 14 days p.i. didsponse observed in MyD88 mice is largely but not en-
tirely mediated by lack of TLR9 signaling. we observe appreciably higher viral titers in the spleens
(Figure 6F) and salivary glands (data not shown) ofTo investigate the extent to which a defect in Ly49H-
mediated viral clearance is responsible for defective TLR9/BALB/c mice in comparison to BALB/c wt con-
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Figure 5. NK Cell Activation in MyD88, TLR9, and Wild-Type Mice during MCMV Infection
MyD88 (A–E), TLR9 (F–H), and wild-type mice were infected intraperitoneally with 5  104 PFU (A–E) or 2  104 PFU (F–H) MCMV. Expression
of CD69 (A) and intracellular IFN- (B) in splenic MyD88 NK cells was measured by flow cytometry gating on CD3/NK1.1 splenocytes
(mean  SD, n 
 3). A representative intracellular IFN- staining is shown in (C). The percentage of proliferating NK cells in the spleens of
wild-type and MyD88 mice was determined 2 days after infection with MCMV by a 3 hr in vivo BrdU incorporation assay (mean  SD, n 

10) (D). Lytic activity of MyD88 NK cells was tested against the RMA-S cell line at the indicated effector to target ratios (E). NK cells were
isolated from the spleens of two wild-type and two MyD88 mice 36 hr after infection with MCMV i.p. as well as from an uninfected wild-type
mouse. TLR9 NK cell expression of CD69 (F) and intracellular IFN- (G) were measured by flow cytometry gating on CD3/DX5 splenocytes
(mean  SD, n 
 3). (H) Intracellular IFN- staining in liver NK cells isolated from infected wild-type and TLR9 mice (gated on CD3/DX5
cells). The percentage of IFN- cells and the mean fluorescence intensity are indicated.
trols. Since expansion of specific CD8 T cells has oc- NK cells cannot efficiently control MCMV replication
(those that lack Ly-49H), TLR9/MyD88 deficiency causescurred by day 14, we speculated that the increased viral
titers in TLR9 BALB/c at this time may reflect a defect a significant increase in already high levels of MCMV
replication only 2 weeks after the infection, possibly duein their CD8 T cell responses. To test this hypothesis,
we measured the percentage of MCMV (immediate early to impaired specific CTL responses that occur after the
immediate NK cell response.gene 1)-specific CD8 T cells in the blood on days 7,
10, and 14 p.i. using H-2Ld/ie1 tetramers. At all time
points examined, TLR9 mice had significantly lower Depletion of IPC Results in Elevated IL-12 Response
to MCMV by Non-IPCpercentages of tetramer-positive CD8 T cells in the
blood than did wt mice (Supplemental Table S1 on Im- While IPC mediate type I IFN and IL-12 responses to
MCMV infection in a TLR9-dependent fashion, other cellmunity’s website).
Together, these results demonstrate that the TLR9/ types, including DC and macrophages, may also secrete
proinflammatory cytokines in a TLR9-dependent orMyD88 pathway is critically important for activating early
NK cell responses to MCMV. In mice in which NK cells -independent manner. To specifically assess the role
of IPC in systemic cytokine responses to MCMV, weare important for controlling MCMV infection (those that
express Ly-49H), TLR9/MyD88 deficiency results in a depleted IPC in vivo using a mAb specific for the IPC-
associated antigen mPDCA-1. The specificity of thisdramatic increase in MCMV replication. In mice in which
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Figure 6. Splenic MCMV Titers in Infected
MyD88 and TLR9 Mice
(A and B) MyD88 and wild-type mice (all on
the C57BL/6 background) were infected i.p.
with 5 104 PFU MCMV. Splenic MCMV titers
were determined by plaque assay 3.5 days
([A], n 
 6) and 6 days ([B], n 
 3) after in-
fection.
(C) TLR9/B6 and C57BL/6 wild-type mice
were infected with 5  104 PFU MCMV i.p.,
and splenic MCMV titers were measured after
3 days (n 
 3).
(D) TLR9 and wild-type mice (all on the
BALB/c background) were infected with 5 
103 or 1  104 PFU MCMV i.p., and splenic
MCMV titers were measured after 3 days ([D],
n 
 8), 6 days ([E], n 
 6), and 14 days ([F],
n 
 5). Viral titers are shown as logarithmic
values of PFU per 100 mg spleen tissue.
Dashed lines designate the detection limit of
the assay. Mean values are indicated by a
solid line. Statistically significant differences
are indicated by asterisks (p 	 0.05).
mAb for mouse IPC was established by demonstrating TLR9/MyD88 pathway in vitro and in vivo. This TLR9-
dependent early cytokine response is critical for activa-that the staining pattern of anti-mPDCA-1 substantially
tion of NK cells, which are licensed to kill MCMV-infectedoverlaps with that of the recently described IPC-specific
cells if equipped with the m157-specific Ly49H receptor.mAb 440c (Blasius et al., 2004) (Supplemental Figure S3
Several lines of evidence support this conclusion. IPCon Immunity’s website and Fischer et al., unpublished
and splenic DC lacking MyD88 or TLR9 exhibited a sig-data). The capacity of anti-mPDCA-1 mAb to deplete
nificant reduction of cytokine secretion and upregulationIPC was demonstrated by staining IPC in various organs
of costimulatory molecules during in vitro culture withex vivo with mAb 440c before and after depletion (Sup-
MCMV. Defective activation of IPC, DC, and possiblyplemental Figure S4 on Immunity’s website).
other cell types led to reduced serum amounts of IFN-,Intraperitoneal (ip) injection of a single depleting dose
IL-12, and MIP-1 during MCMV infection in vivo. Im-of 500 g of anti-mPDCA-1 mAb 24 hr before MCMV
paired cytokine secretion in MCMV-infected MyD88infection yielded an incomplete IPC depletion when
and TLR9 mice correlated with diminished NK cell acti-compared to controls (approximately 80% depletion,
vation, proliferation, cytotoxicity, and IFN- secretion.Supplemental Figure S4 on Immunity’s website). As a
Attenuation of cytokine-mediated NK cell activation didresult, the IFN- response 36 hr after MCMV infection
not significantly exacerbate infection in MCMV-susceptiblewas only partially impaired and other inflammatory cyto-
BALB/c mice, which lack specific mechanisms for NKkines, including IL-12 and IFN-, were unaffected (data
cell recognition of MCMV. In contrast, both MyD88 andnot shown). When a more vigorous regimen of three
TLR9 deficiency drastically reduced the ability of NK
injections (of 500 g mAb each) was undertaken, IPC
cells bearing the Ly49H receptor specific for MCMV to
depletion was more complete. In these circumstances, control viral replication in B6 mice. Direct triggering of
we found that serum IFN- was markedly reduced (Fig- Ly49H NK cells by MCMV via TLR9 was excluded,
ure 7). In contrast, serum levels of IL-12 p70 and IFN- because NK cells do not express TLR9 and purified
were significantly higher in IPC depleted animals than splenic NK cells do not respond to TLR9 agonists in vitro.
in mice treated with a control antibody (Figure 7). We How does TLR9 function as pattern recognition recep-
also observed that NK cell activity at 36 hr and MCMV tor for MCMV? TLR9 recognizes unmethylated CpG mo-
titers in the spleen at day 3 after infection were similar tifs present in bacterial DNA and immunostimulatory
in control and IPC-depleted C57BL/6 mice (data not oligonucleotides (Hemmi et al., 2000; Krieg, 2002), as
shown). Together, these results indicate that the ab- well as chromatin-IgG immune complexes (Leadbetter
sence of an IPC-mediated IFN- response to MCMV is et al., 2002). CpG-motifs are abundant in the genomes
effectively counterbalanced by increased secretion of of andherpesviruses, such as HSV and MCMV (Lund-
inflammatory cytokines by non-IPC. berg et al., 2003). Because these genomes are not highly
methylated, the immunostimulatory capacity of CpG
Discussion motifs is probably preserved. Thus, TLR9-dependent
recognition of MCMV, HSV-1, and HSV-2 is most likely
In this study, we demonstrate that MCMV provokes IPC due to unmethylated CpG motifs within the viral ge-
nomes.and DC secretion of type I IFNs and IL-12 through the
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bly other cell types in maintaining effective levels of
proinflammatory cytokines during viral infection. In
agreement with our study, it has been shown that in vivo
treatment with the anti-Gr-1 antibody, which depletes
IPC and granulocytes, abrogates type I IFN release 36
hr after MCMV infection, whereas IL-12 levels are un-
changed, and conventional DCs secrete increased
amounts of IL-12 (Asselin-Paturel et al., 2001; Dalod et
al., 2002). This coordinated cytokine secretion by IPC
and DC is due to the ability of type I IFN to inhibit IL-
12 secretion (Cousens et al., 1997; Dalod et al., 2002;
Dzionek et al., 2002) and ensures compensation for the
lack of IFN- signaling during infections by viruses that
deplete IPC, including human immunodeficiency virus
(HIV) (Chehimi et al., 2002; Siegal and Spear, 2001), or
interfere at different levels with IFN- signaling (Garcia-
Figure 7. Serum Cytokines after IPC Depletion during MCMV In-
Sastre, 2002; Katze et al., 2002). Furthermore, regulationfection
of IL-12 secretion by IFN- may promote optimal cyto-MCMV infection following the depletion of IPC in vivo shows an
kine-mediated activation of cytotoxic lymphocytes, min-impaired IFN- response that is paralleled by overproduction of IL-
imizing apoptosis induced by high levels of IL-1212 p70 and IFN-. C57Bl/6 mice were either injected three times i.v.
with 500 g anti-mPDCA-1 mAb at time points 24 hr, 4 hr before, (Cousens et al., 1997).
and 20 hr after infection (white circles, n 
 4) or were left untreated Although the TLR9/MyD88 pathway is critical for early
(filled circles, n 
 3). Blood sera were collected 36 hr after the i.p. cytokine secretion in response to MCMV infection, a
infection with 5  104 PFU. Serum cytokines were determined by
diminished and delayed cytokine response is still de-IFN- ELISA and by cytokine bead array (CBA, BD Biosciences) for
tected in the absence of MyD88 or TLR9, suggesting theIL-12 p70 and IFN-.
involvement of additional cells and pathways in cytokine
responses. These pathways could be initiated by cell
surface receptors that directly interact with MCMV andIt is not clear how viral DNAs get into the acidified
transduce intracellular signals. The epidermal growthendosomal compartment where TLR9 is expressed and
factor receptor provides a precedent for this mecha-initiate MyD88-dependent signaling (Ahmad-Nejad et
nism, as it binds HCMV and transduces intracellularal., 2002). At least two scenarios can be proposed. It
signals (Wang et al., 2003). Alternatively, cytokine re-is possible that after receptor-mediated internalization,
sponses could be triggered by other TLRs that signalMCMV reaches an endosomal compartment. There, the
independently of MyD88. Recently, TLR3 and TLR4 wereviral envelope disintegrates, exposing the uncoated
shown to signal through the adaptor TRIF/TICAM-1,DNA-capsid complex for interaction with TLR9. This
which triggers IFN- production (Oshiumi et al., 2003;
could explain why activation of IPC and DC by MCMV
Yamamoto et al., 2002, 2003a). In addition, TLR4 can
and HSV is independent of active viral replication (Dalod
signal through another adaptor called TRAM (Oshiumi
et al., 2002; Krug et al., 2004; Lund et al., 2003). Irrespec-
et al., 2003; Yamamoto et al., 2003b). Thus, the residual
tive of the details, replication-independent activation cytokine production observed in MCMV-infected MyD88
is extremely advantageous for the host, as responses and TLR9 mice could possibly be attributed to MyD88-
triggered before the beginning of viral replication protect independent pathways triggered by TLR3 or TLR4 inter-
other cells from infection. An alternative scenario may acting with yet unidentified MCMV ligands.
be envisaged for cells other than IPC, in which MCMV Consistent with this hypothesis, TLR3-deficient mice
is actively replicating. Here, the DNA-capsid complex and mice carrying the LPS2 mutation, which causes a
may reach the nucleus to initiate DNA replication and selective defect in the TRIF adaptor molecule, are highly
viral assembly. During viral replication, defective viral susceptible to MCMV infection and have dramatically
particles might be sequestered in the endosomal path- reduced type I IFN levels in the serum after infection
way, where the DNA could be exposed to TLR9. with a high dose of MCMV (Hoebe et al., 2003; Tabeta
Although our study focuses on IPC and DC responses et al., 2004). Because murine IPC do not express func-
to MCMV, other cell types are likely to secrete cytokines tionally significant levels of TLR3 or TLR4, MyD88-inde-
in response to MCMV, particularly macrophages. Thus, pendent cytokine production in response to MCMV
it is important to define the individual contribution of in vivo must occur in cells other than IPC, probably
each cell type to anti-MCMV responses. Here, we specif- dendritic cells or macrophages that express TLR3 and
ically investigated the role of IPC by depleting them TLR4. TLR9/MyD88-dependent and TRIF-dependent
with an antibody. Remarkably, although IPC depletion signaling pathways are probably both required for the
substantially reduced the IFN- response to MCMV, sys- generation of effective IPC and DC responses to MCMV
temic IL-12 was actually elevated due to secretion by and may be partially interdependent.
non-IPC. As a result, systemic IFN- was also either Notably, we observed that MCMV titers are to some
maintained or increased and NK cells were activated, extent higher in MyD88 mice than in TLR9 mice. Since
ensuring substantial control of splenic MCMV titers. MyD88 is required not only for TLR9 signaling but also
These results confirm that IPC produce most of early for signal transduction downstream of IL-1R and IL-
type I IFN to MCMV in vivo. In addition, they reveal 18R (Adachi et al., 1998), a defect in the IL-1 and IL-
18 signaling pathways may also contribute to the highextraordinary coordination between IPC, DC, and possi-
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VirusesMCMV titers observed in MyD88 mice. However, when
Smith strain MCMV was a generous gift of H. Virgin (Washingtonwe analyzed splenic MCMV titers and survival of wt,
University, St. Louis, MO). A tissue culture MCMV stock was pre-MyD88/B6, IL-18/B6, and IL-18R/B6 mice after high-
pared by propagating MCMV in NIH3T12 fibroblasts (ATCC). The
dose MCMV infection, MyD88 mice were far more sus- viral titer was determined in a standard plaque assay (1.8  107
ceptible to MCMV infection than were IL-18 and IL- PFU/ml). MCMV tissue culture stock was used in vitro at 0.008-2
MOI. A salivary gland MCMV stock was prepared from BALB/c mice18R mice, which behaved almost as wt mice (data not
that had been injected intraperitoneally (i.p.) with 1  106 PFU ofshown). We conclude that the lack of IL-18 signaling
MCMV propagated in tissue culture. For in vivo experiments, micemay contribute to but cannot account for the severe
were injected i.p. with 2  103  5  104 PFU/mouse from a salivarydefect in immune response to MCMV observed in
gland stock of MCMV with a titer of 3.6  106 PFU/ml. Influenza
MyD88 mice. The contribution of IL-1 signaling to anti- virus PR8 was propagated and titered in MDCK cells and used
MCMV innate responses remains to be determined. in vitro at 1–2 MOI.
Type I IFN is well known for activating cellular mecha-
nisms that interfere with viral replication (Garcia-Sastre, MCMV Plaque Assay
MCMV titers were determined in a standard plaque assay (Brown2002). Thus, IPC-mediated secretion of type I IFN may
et al., 2001). In brief, spleens from infected animals were harvestedpartially contribute to direct inhibition of MCMV replica-
3 or 6 days after infection, weighed, and frozen in 1 ml culturetion. Accordingly, we detected a moderate inhibitory
medium (DMEM [Gibco] with 10% BCS [Hyclone], 1% glutamax,
effect of recombinant IFN- on MCMV replication in vitro 1% sodium-pyruvate, and 1% kanamycin). Spleens were thawed
(Supplemental Figure S5 on Immunity’s website). How- and homogenized with dounce homogenizers on ice. Monolayers
of NIH3T12 cells in 6-well plates were infected with serial dilutionsever, we observed relatively high levels of viral replica-
of spleen homogenates in triplicate. After 1 hr of incubation at 37C,tion in both TLR9 BALB/c and wild-type BALB/c infected
cells were covered with an overlay of DMEM/5% BCS/0.5% noblemice, although the amount of IFN- was significantly
agar (Difco). Cells were overlaid again after 3 days. On day 4, plaqueslower in the serum of infected TLR9 mice than infected were counted using a light microscope with 4 magnification.
BALB/c controls. Thus, type I IFN secreted by IPC ap-
pears to play a major function in activating host immune Isolation and Culture of IPC and DC
responses against viruses. Our demonstration that Spleen DC were isolated with CD11c microbeads (Miltenyi Biotec,
Bergisch-Gladbach, Germany). IPC (CD11c/Ly-6C/CD11b cells),MyD88 and TLR9 B6 mice have dramatically increased
CD11bDC (CD11c/Ly-6C/CD11b cells, which comprise myeloidsplenic MCMV titers in comparison to infected wild-type
DC), and CD11b DC (CD11c/Ly-6C/CD11b cells, which compriseB6 mice suggests that type I IFN, together with IL-12,
CD8 or “lymphoid” DC) were sorted from CD11c splenocytes
is essential for activating NK cells, which can specifically using a MoFlo cytometer (Cytomation, Fort Collins, Colorado;95%
kill MCMV-infected cells if they express Ly49H. Our purity) as previously described (Krug et al., 2004). Bone marrow-
study also indicates that TLR9/MyD88-mediated type I derived IPC were generated from bone marrow cells by culture with
human recombinant Flt3L (10 ng/ml, R&D Systems) for 7 days andIFN responses may partially contribute to expansion of
purified by sorting the CD11c/CD11blow population as described.specific CD8 T cells. Based on previous studies (Biron,
Cells were cultured with MCMV propagated in tissue culture (0.0082001; Jego et al., 2003; Le Bon et al., 2001), further
to 2 MOI), CpG ODN 2216 (3 g/ml), or influenza virus PR8 (1 MOI)
effects of type I IFN on DC and antibody responses to at the indicated cell density. After 36 hr, cell-free supernatants were
MCMV are likely but remain to be substantiated. collected for detection of IFN- and IL-12 by ELISA and cells were
harvested for flow cytometric analysis of CD86 expression.In conclusion, our study shows that TLR9/MyD88-
dependent secretion of IFN- and IL-12 by IPC and DC
Media, CpG ODN, and Cytokinesis critical for effective control of MCMV replication by
RPMI 1640 (Gibco/Invitrogen) with 10% FCS (Hyclone), 1% gluta-Ly49H NK cells. This provides evidence for a role of
max, 1% Na-pyruvate, 1% nonessential amino acids, 1% kanamycin
TLR9 in mediating help between different subsets of (Gibco/Invitrogen), and 50 M -mercaptoethanol was used as cul-
cells involved in innate immune responses against sys- ture medium for in vitro experiments throughout. CpG ODN 2216
temic viral infections. (5-gggggacgatcgtcgggggg-3) was obtained from Qiagen (Valen-
cia, CA), recombinant murine IFN- from PBL Biomedical Labora-
tories (New Brunswick, NJ), and recombinant murine IL-12 from
Experimental Procedures Peprotech (Rocky Hill, NJ).
Mice ELISAs, Cytometric Bead Array, Antibodies, and Flow Cytometry
MyD88 and TLR9 mice have been described (Adachi et al., 1998; IFN-, IL-12p40, and MIP-1 in culture supernatants or sera were
Hemmi et al., 2000). MyD88 mice were backcrossed to C57BL/6, measured by ELISA (PBL Biomedical Laboratories, New Brunswick,
TLR9mice to C57BL/6 and BALB/c. Age-matched wild-type control NJ; BD Biosciences, Franklin Lakes, NJ; R & D Systems, Minneapo-
C57BL/6 and BALB/c mice were obtained from Taconic (German- lis, MN). The IFN- ELISA detects IFN-A, -1, -4, -5, -6, and
town, NY). Mice were maintained under specific pathogen-free con- -9. IL-12p70 and IFN- in mouse sera were also determined by
ditions and experiments were conducted in accordance with institu- flow cytometry using the mouse inflammation CBA according to
tional guidelines for animal care and use. To assess the genetic instructions by the manufacturer (BD Biosciences). For flow cyto-
background composition of the MyD88- and TLR9-deficient mice metric analysis, IPC were stained with biotinylated anti-CD86 fol-
used in this study, we performed a gene scan analysis in the Rheu- lowed by streptavidin-APC. NK cells were identified within spleno-
matic Diseases Core Center, looking at background-specific mark- cytes or liver leucocytes by staining with anti-CD3-FITC or PerCP
ers of all chromosomes, including the natural killer cell complex and DX5-APC or NK1.1-APC, as indicated. Cells were then stained
(NKC). From the TLR9/BALB/c, 112 of 119 analyzed genes (94%) with anti-CD69 PE or fixed, permeabilized, and stained intracellularly
were BALB/c, including the NKC. From the MyD88/C57BL/6 back- with anti-IFN- PE. In some experiments FITC-labeled anti-IFN-
ground 88 of 135 analyzed genes (65%) were C57BL/6, including was used. All antibodies used for flow cytometry were obtained
the NKC. From the TLR9/C57BL/6 146 of 151 (95%) analyzed genes from BD Biosciences (San Jose, CA). Stained cell samples were
were C57BL/6146, including the NKC. We validated expression (or analyzed on a FACSCalibur flow cytometer. To determine CTL re-
lack of expression) of NK1.1 and Ly49H on NK cells of all mice by sponses to MCMV, whole blood was stained with a PE-labeled
tetramer of H-2Ld/YPHFMPTNL complex (Proimmune), followed byflow cytometry.
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